4/A
Changes in Ownership
SpyGlass Pharma, Inc. Filed Acc 0001193125-26-046833
Options or other derivatives
- Director acquired 3,145,619 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Nielsen Kirk G. Director | 2026-02-09 | Conversion · Series B Preferred Stock | −1,690,230 | 0 | I | ||
| Nielsen Kirk G. Director | 2026-02-09 | Conversion · Series C-1 Preferred Stock | −548,067 | 0 | I | ||
| Nielsen Kirk G. Director | 2026-02-09 | Conversion · Series C-2 Preferred Stock | −548,067 | 0 | I | ||
| Nielsen Kirk G. Director | 2026-02-09 | Conversion · Series D Preferred Stock | −359,255 | 0 | I | ||
Loading xslF345X05/ownership.xml…